57.20

1.41% -0.82

After Hours: 57.30 0.10 +0.17%

Transmedics Group Inc (TMDX)

Overview News Price History Option Chain Financials Why TMDX Down? Discussions Forecast

Transmedics Group Inc stock is traded at $57.20, with a volume of 2.65M. It is down -1.41% in the last 24 hours and down -12.94% over the past month. TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Previous Close:

$58.02

Open:

$58.38

24h Volume:

2.65M

Relative Volume:

1.23

Market Cap:

$1.92B

Revenue:

$401.09M

Net Income/Loss:

$32.64M

P/E Ratio:

60.85

EPS:

0.94

Net Cash Flow:

$-120.51M

1W Performance:

-16.87%

1M Performance:

-12.94%

6M Performance:

-61.67%

1Y Performance:

-27.28%

1-Day Range:

$56.03

$58.85

1-Week Range:

$56.03

$67.80

52-Week Range:

$56.03

$177.37

Transmedics Group Inc Stock (TMDX) Company Profile

Name

Transmedics Group Inc

Sector

Healthcare (1174)

Industry

Medical Devices (160)

Phone

(978) 552-0900

Address

200 MINUTEMAN ROAD, ANDOVER, MA

Employee

584

Twitter

@transmedics

Next Earnings Date

2024-10-28

Latest SEC Filings

TMDX's Discussions on Twitter

Compare TMDX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMDX Transmedics Group Inc	57.20	1.92B	401.09M	32.64M	-120.51M	0.94
ABT Abbott Laboratories	113.48	196.83B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	383.42	146.17B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	98.66	145.41B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	88.08	112.94B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	69.78	41.16B	6.60B	4.16B	490.10M	6.93

Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Downgrade	JP Morgan	Overweight → Neutral
Nov-22-24	Downgrade	Needham	Buy → Hold
Oct-29-24	Reiterated	Needham	Buy
Oct-29-24	Reiterated	Oppenheimer	Outperform
Sep-24-24	Initiated	Robert W. Baird	Outperform
Aug-21-24	Initiated	Needham	Buy
Jun-06-24	Initiated	Cantor Fitzgerald	Overweight
Jun-04-24	Initiated	Stephens	Overweight
Mar-28-24	Initiated	Piper Sandler	Overweight
Jul-19-23	Initiated	Robert W. Baird	Outperform
Aug-02-22	Upgrade	JP Morgan	Neutral → Overweight
Oct-08-20	Downgrade	JP Morgan	Overweight → Neutral
Apr-07-20	Initiated	Oppenheimer	Outperform
May-28-19	Initiated	Canaccord Genuity	Buy
May-28-19	Initiated	Cowen	Outperform
May-28-19	Initiated	JP Morgan	Overweight
May-28-19	Initiated	Morgan Stanley	Equal-Weight

View All

Transmedics Group Inc Stock (TMDX) Latest News

Jan 19, 2025

TransMedics Group (NASDAQ:TMDX) Hits New 12-Month LowWhat's Next? - MarketBeat

Jan 19, 2025

Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action InvestigationTMDX - PR Newswire

Jan 19, 2025

Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX) - Simply Wall St

Jan 19, 2025

Jan 18, 2025

TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. - The Bakersfield Californian

Jan 18, 2025

TransMedics Group, Inc. Announcement: If You Have Suffered Losses in TransMedics Group, Inc. (NASDAQ: TMDX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.

Jan 18, 2025

When the Price of (TMDX) Talks, People Listen - Stock Traders Daily

Jan 18, 2025

Brokerages Set TransMedics Group, Inc. (NASDAQ:TMDX) Target Price at $122.70 - MarketBeat

Jan 18, 2025

TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Jan 18, 2025

TransMedics Stock: Expectations Remain Sky-High Despite Recent Stock Drop (NASDAQ:TMDX) - Seeking Alpha

Jan 18, 2025

Jan 17, 2025

TransMedics Group (NASDAQ:TMDX) Reaches New 1-Year LowHere's Why - MarketBeat

Jan 17, 2025

TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman - GlobeNewswire

Jan 17, 2025

Looking At TransMedics Gr's Recent Unusual Options Activity - Benzinga

Jan 17, 2025

TMDX Stock Touches 52-Week Low at $58.27 Amid Market Challenges - Investing.com Australia

Jan 17, 2025

Why TransMedics Fell 15.7% This Week - MSN

Jan 17, 2025

TMDX Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors with Significant Losses to Contact the Firm - Kilgore News Herald

Jan 17, 2025

Why TransMedics Group (TMDX) Stock is Moving Today - GuruFocus.com

Jan 17, 2025

Transmedics (TMDX) Fell on Investors’ Growing Concerns - Yahoo Finance

Jan 17, 2025

Jan 16, 2025

TMDX Stock Touches 52-Week Low at $58.27 Amid Market Challenges By Investing.com - Investing.com South Africa

Jan 16, 2025

Kirby McInerney LLP Announces Investigation Against TransMedics Group, Inc. (TMDX) on Behalf of Investors - GlobeNewswire

Jan 16, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation - Markets Insider

Jan 16, 2025

Why Transmedics Plunged in December - MSN

Jan 16, 2025

TransMedics faces fraud, organ trafficking accusations from activist short seller - Mass Device

Jan 16, 2025

NASDAQ: TMDX Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors with Significant Losses to Contact the Firm - Business Wire

Jan 15, 2025